Gerresheimer AG, DE000A0LD6E6
Gerresheimer AG: Release according to Article 40 Section 1 of ...
Gerresheimer AG / DE000A0LD6E6
dgap.de, 15.01.25 04:06 Uhr
Eisai, BioTech
FDA Accepts LEQEMBI Biologics License Application for Subcutaneous ...
LEQEMBI is the only FDA-approved anti-amyloid therapy that potentially could offer the convenience
japancorp.net, 15.01.25 03:45 Uhr
Mizuho Financial Group, Metals & Mining
TANAKA's Group Company EEJA to Exhibit at 39th NEPCON JAPAN. ...
TANAKA's Group Company EEJA to Exhibit at 39th NEPCON JAPAN
japancorp.net, 15.01.25 03:03 Uhr
HYTN Innovations Inc., CA40443L1040
HYTN sichert sich zusätzliche Genehmigungen für die Ausweitung ...
